Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | FDPS | P14324 | 3/20 | 0.38 |
| ▸ | GAA | P10253 | 2/20 | 0.38 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL380588 | 0.85 | ALDH1A1 (0.46) | ALDH1A1LMNAHTTFDPSGAA | |
| SCHEMBL7693599 | 0.85 | FDPS (0.44) | FDPSGAA | |
| SCHEMBL27562470 | 0.83 | FDPS (0.46) | FDPSGAA | |
| SCHEMBL9615912 | 0.80 | — | — | |
| SCHEMBL6912305 | 0.80 | ALDH1A1 (0.42) | ALDH1A1LMNAHTTFDPSGAA | |
| SCHEMBL380063 | 0.80 | ALDH1A1 (0.42) | ALDH1A1LMNAHTTFDPSGAA | |
| SCHEMBL11202301 | 0.76 | ALDH1A1 (0.64) | ALDH1A1LMNACYP2C19KDM4ETSHR | |
| SCHEMBL9084194 | 0.76 | TDP1 (0.44) | ALDH1A1LMNAHTTGAAALOX12 | |
| SCHEMBL9083965 | 0.76 | TDP1 (0.44) | ALDH1A1LMNAHTTGAAALOX12 | |
| SCHEMBL1333057 | 0.76 | ALDH1A1 (0.64) | ALDH1A1LMNACYP2C19KDM4ETSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 161 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12617957-B2 | Durable outdoor inkjet inks | INTERNATIONAL IMAGING MATERIALS, INC. (US) | 2026-05-05 | — | — | US | disclosed |
| EP-3870656-B1 | ACRYLIC POLYMERS FOR INKJET INK APPLICATIONS | CABOT CORP (US) | 2026-03-18 | — | — | EP | disclosed |
| US-12018162-B2 | Acrylic polymers for inkjet ink applications | CABOT CORPORATION (US) | 2024-06-25 | — | — | US | disclosed |
| EP-3294813-B1 | AMPHOTERIC POLYMERS AND USE IN INKJET INK COMPOSITIONS | CABOT CORP (US) | 2024-06-12 | — | — | EP | disclosed |
| EP-4248010-A1 | DIGITAL TEXTILE PRINTING INKS HAVING ZERO VOLATILE ORGANIC COMPOUND SOLVENTS THEREIN | International Imaging Materials Inc. (US) | 2023-09-27 | — | — | EP | disclosed |
| CN-112955510-B | Acrylic polymers for inkjet ink applications | 卡博特公司 | 2023-07-11 | — | — | CN | disclosed |
| US-11413896-B2 | Digital textile printing inks having zero volatile organic compound solvents therein | INTERNATIONAL IMAGING MATERIALS, INC. (US) | 2022-08-16 | — | — | US | disclosed |
| WO-2022108648-A1 | DIGITAL TEXTILE PRINTING INKS HAVING ZERO VOLATILE ORGANIC COMPOUND SOLVENTS THEREIN | INTERNATIONAL IMAGING MATERIALS, INC. (US) | 2022-05-27 | — | — | WO | disclosed |
| US-20220153047-A1 | DIGITAL TEXTILE PRINTING INKS HAVING ZERO VOLATILE ORGANIC COMPOUND SOLVENTS THEREIN | INTERNATIONAL IMAGING MATERIALS, INC. (US) | 2022-05-19 | — | — | US | disclosed |
| US-20220154019-A1 | DIGITAL TEXTILE PRINTING INKS HAVING ZERO VOLATILE ORGANIC COMPOUND SOLVENTS THEREIN | INTERNATIONAL IMAGING MATERIALS, INC. (US) | 2022-05-19 | — | — | US | disclosed |
| US-6613815-B2 | Water, a colorant, and ethylene oxide-propylene oxide-spacer-siloxane block copolymer; dry time is decreased to reduce bleeding between colors | XEROX CORPORATION | 2003-09-02 | — | — | US | disclosed |
| US-20030060537-A1 | Ink jet ink composition comprising inter-color bleed additive and printing processes using the same | XEROX CORPORATION | 2003-03-27 | — | — | US | disclosed |
| US-6528557-B2 | Ink containing a polyoxyalkylene glycol-polysiloxane block copolymer having optional spacer groups of given formula; multicolor ink jet printing with reduced dry time and/or intercolor bleed | XEROX CORPORATION | 2003-03-04 | — | — | US | disclosed |
| US-6475271-B2 | WATER, A COLORANT, AND A LOW BOILING POINT PENETRANT ADDITIVE HAVING A BOILING POINT LESS THAN OR EQUAL TO ABOUT 115 DEGREES C.; HIGH QUALITY IMAGES WITH MINIMAL INTERCOLOR BLEED AND LOW MFLEN. | XEROX CORPORATION | 2002-11-05 | — | — | US | disclosed |
| US-20020156155-A1 | Inks comprising linear ABSCS'B'A' or BASCS'A'B' alkylene oxide/siloxane block copolymers | XEROX CORPORATION | 2002-10-24 | — | — | US | disclosed |
| US-20020151619-A1 | Inks comprising linear Asbs'A' block copolymers of alkylene oxide and siloxane | XEROX CORPORATION | 2002-10-17 | — | — | US | disclosed |
| US-20020121220-A1 | Ink jet ink compositions and printing processes | XEROX CORPORATION | 2002-09-05 | — | — | US | disclosed |
| EP-1219688-A1 | Ink jet ink compositions and printing processes | Xerox Corporation (US) | 2002-07-03 | — | — | EP | disclosed |
| EP-0945496-A1 | Ink compositions and multicolor thermal ink jet printing process for the production of high quality images | Xerox Corporation (US) | 1999-09-29 | — | — | EP | disclosed |
| US-5958121-A | SET OF INKS COMPRISING FIRST AQUEOUS INK CONSISTING OF ANIONIC COLORANT, SECOND AQUEOUS INK CONTAINING AMMONIUM SALT, WHEREIN FIRST COLORANT IS IMMOBILIZED ON SUBSTRATE BY INTERACTION WITH AMMONIUM SALT, REDUCING INTERCOLOR BLEED | XEROX CORPORATION (US) | 1999-09-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12617957-B2 | Durable outdoor inkjet inks | MARK3, MCM7, MARK4 | ALDH1A1 319/4885LMNA 1489/4885HTT 632/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.